Daniela Kleine-Kohlbrecher

Company: Evaxion Biotech

Job title: Project Director, Immuno-Oncology

Seminars:

Fireside Chat: Creating Alignment in Immune Monitoring & Interpretation of Read Outs to Increase Investment Opportunities & Accurately Measure Clinical Efficacy 4:00 pm

Creating a robust, methodical protocol for monitoring and analysing immune response to enable investors to contextualise and compare therapeutic efficacy Ensuring appropriate read outs and biomarkers are selected for immune monitoring to accurately evaluate immunogenicity of neoantigen vaccines and cell therapies Determining a desired level of de novo and secondary immune response to quantify efficacyRead more

day: Day Two

Phase 2 Study of AI-Designed Personalised Neoantigen Cancer Vaccine, EVX-01, in Combination With Pembrolizumab in Advanced Melanoma 9:30 am

Discussing AI designed personalised peptide vaccines Understanding the phase 2 clinical testing Considering antigen specific T-cell responses and Biomarker analysisRead more

day: Day One